Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | ectonucleotide pyrophosphatase:phosphodiesterase | 0.0062 | 0.1749 | 0.5886 |
Trypanosoma cruzi | DNA/RNA non-specific endonuclease protein-like, putative | 0.0037 | 0.0756 | 0.2543 |
Schistosoma mansoni | kinase | 0.0047 | 0.1147 | 0.1147 |
Schistosoma mansoni | endonuclease related | 0.0037 | 0.0756 | 0.0756 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0093 | 0.2972 | 0.2972 |
Echinococcus multilocularis | serine:threonine protein kinase PLK1 | 0.0093 | 0.2972 | 1 |
Onchocerca volvulus | Serine\/threonine kinase homolog | 0.0093 | 0.2972 | 0.4241 |
Echinococcus granulosus | ectonucleotide pyrophosphatase:phosphodiesterase | 0.0062 | 0.1749 | 0.5886 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0045 | 0.1058 | 0.1058 |
Loa Loa (eye worm) | hypothetical protein | 0.0062 | 0.1749 | 0.1749 |
Loa Loa (eye worm) | glutaminase 2 | 0.0269 | 1 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0093 | 0.2972 | 0.2972 |
Echinococcus granulosus | ectonucleotide pyrophosphatase:phosphodiesterase | 0.0062 | 0.1749 | 0.5886 |
Leishmania major | endonuclease G, putative | 0.0037 | 0.0756 | 0.2543 |
Leishmania major | protein kinase, putative,polo-like protein kinase, putative | 0.0093 | 0.2972 | 1 |
Echinococcus granulosus | ectonucleotide pyrophosphatase:phosphodiesterase | 0.0062 | 0.1749 | 0.5886 |
Echinococcus granulosus | serine:threonine protein kinase PLK1 | 0.0093 | 0.2972 | 1 |
Toxoplasma gondii | DNA/RNA non-specific endonuclease | 0.0037 | 0.0756 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0045 | 0.1058 | 0.1058 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0045 | 0.1058 | 0.356 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0045 | 0.1058 | 0.356 |
Schistosoma mansoni | ectonucleotide pyrophosphatase/phosphodiesterase | 0.0062 | 0.1749 | 0.1749 |
Giardia lamblia | Kinase, PLK | 0.0093 | 0.2972 | 1 |
Trypanosoma cruzi | endonuclease G, putative | 0.0037 | 0.0756 | 0.2543 |
Brugia malayi | Thrombospondin type 1 domain containing protein | 0.0135 | 0.4632 | 0.4632 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0045 | 0.1058 | 0.1058 |
Echinococcus granulosus | ectonucleotide pyrophosphatase:phosphodiesterase | 0.0062 | 0.1749 | 0.5886 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0093 | 0.2972 | 0.2972 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0093 | 0.2972 | 0.2972 |
Trypanosoma brucei | polo-like protein kinase | 0.0093 | 0.2972 | 1 |
Brugia malayi | endonuclease G, mitochondrial precursor | 0.0037 | 0.0756 | 0.0756 |
Echinococcus multilocularis | ectonucleotide pyrophosphatase:phosphodiesterase | 0.0062 | 0.1749 | 0.5886 |
Trypanosoma brucei | endonuclease G, putative | 0.0037 | 0.0756 | 0.2543 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0045 | 0.1058 | 0.1058 |
Trypanosoma brucei | endonuclease G, putative | 0.0037 | 0.0756 | 0.2543 |
Echinococcus granulosus | Endonuclease G | 0.0037 | 0.0756 | 0.2543 |
Schistosoma mansoni | ectonucleotide pyrophosphatase/phosphodiesterase | 0.0062 | 0.1749 | 0.1749 |
Loa Loa (eye worm) | hypothetical protein | 0.0062 | 0.1749 | 0.1749 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0019 | 0 | 0.5 |
Mycobacterium ulcerans | glutaminase | 0.0269 | 1 | 1 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0093 | 0.2972 | 1 |
Brugia malayi | Type I phosphodiesterase / nucleotide pyrophosphatase family protein | 0.0062 | 0.1749 | 0.1749 |
Echinococcus multilocularis | Endonuclease G | 0.0037 | 0.0756 | 0.2543 |
Loa Loa (eye worm) | hypothetical protein | 0.0062 | 0.1749 | 0.1749 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0045 | 0.1058 | 0.356 |
Trypanosoma brucei | endonuclease G, putative | 0.0037 | 0.0756 | 0.2543 |
Echinococcus granulosus | ectonucleotide pyrophosphatase:phosphodiesterase | 0.0062 | 0.1749 | 0.5886 |
Echinococcus multilocularis | ectonucleotide pyrophosphatase:phosphodiesterase | 0.0062 | 0.1749 | 0.5886 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0045 | 0.1058 | 0.356 |
Schistosoma mansoni | glutaminase | 0.0269 | 1 | 1 |
Echinococcus multilocularis | ectonucleotide pyrophosphatase:phosphodiesterase | 0.0062 | 0.1749 | 0.5886 |
Schistosoma mansoni | ectonucleotide pyrophosphatase/phosphodiesterase | 0.0062 | 0.1749 | 0.1749 |
Loa Loa (eye worm) | PLK/PLK1 protein kinase | 0.0093 | 0.2972 | 0.2972 |
Echinococcus multilocularis | ectonucleotide pyrophosphatase:phosphodiesterase | 0.0062 | 0.1749 | 0.5886 |
Echinococcus multilocularis | ectonucleotide pyrophosphatase:phosphodiesterase | 0.0053 | 0.1358 | 0.4569 |
Entamoeba histolytica | serine/threonine protein kinase, putative | 0.0093 | 0.2972 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0135 | 0.4632 | 0.4632 |
Trypanosoma cruzi | DNA/RNA non-specific endonuclease protein-like, putative | 0.0037 | 0.0756 | 0.2543 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0046 | 0.1098 | 0.1098 |
Loa Loa (eye worm) | thrombospondin type 1 domain-containing protein | 0.0135 | 0.4632 | 0.4632 |
Loa Loa (eye worm) | glutaminase | 0.0269 | 1 | 1 |
Trichomonas vaginalis | glutaminase, putative | 0.0269 | 1 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0045 | 0.1058 | 0.1058 |
Leishmania major | DNA/RNA non-specific endonuclease-like protein | 0.0037 | 0.0756 | 0.2543 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0046 | 0.1098 | 0.1098 |
Echinococcus multilocularis | ectonucleotide | 0.0053 | 0.1358 | 0.4569 |
Echinococcus multilocularis | ectonucleotide pyrophosphatase:phosphodiesterase | 0.0062 | 0.1749 | 0.5886 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0019 | 0 | 0.5 |
Echinococcus granulosus | ectonucleotide | 0.0053 | 0.1358 | 0.4569 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0093 | 0.2972 | 0.2972 |
Loa Loa (eye worm) | hypothetical protein | 0.0053 | 0.1358 | 0.1358 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0093 | 0.2972 | 1 |
Onchocerca volvulus | 0.0135 | 0.4632 | 1 | |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0019 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0093 | 0.2972 | 0.2972 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0093 | 0.2972 | 0.2972 |
Brugia malayi | serine/threonine-protein kinase plk-2 | 0.0093 | 0.2972 | 0.2972 |
Echinococcus granulosus | ectonucleotide pyrophosphatase:phosphodiesterase | 0.0053 | 0.1358 | 0.4569 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0019 | 0 | 0.5 |
Trypanosoma cruzi | endonuclease G, putative | 0.0037 | 0.0756 | 0.2543 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0093 | 0.2972 | 0.2972 |
Schistosoma mansoni | ectonucleotide pyrophosphatase/phosphodiesterase | 0.0062 | 0.1749 | 0.1749 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MIC (functional) | = 48.4 ug ml-1 | Inhibitory activity against Candida albicans (40 clinical isolates), determined at pH-7.2 | ChEMBL. | 7473549 |
MIC (functional) | = 48.4 ug ml-1 | Inhibitory activity against Candida albicans (40 clinical isolates), determined at pH-7.2 | ChEMBL. | 7473549 |
MIC (functional) | = 51.6 ug ml-1 | Inhibitory activity against Candida. species. (40 clinical isolates), determined at pH-7.2 | ChEMBL. | 7473549 |
MIC (functional) | = 71 ug ml-1 | Inhibitory activity against Candida. species. (40 clinical isolates), determined at pH-5.8 | ChEMBL. | 7473549 |
MIC (functional) | = 133.3 ug ml-1 | Inhibitory activity against Candida albicans (40 clinical isolates), determined at pH-5.8 | ChEMBL. | 7473549 |
MIC (functional) | = 133.3 ug ml-1 | Inhibitory activity against Candida albicans (40 clinical isolates), determined at pH-5.8 | ChEMBL. | 7473549 |
MIC50 (functional) | = 32 ug ml-1 | 50% inhibitory activity against Candida albicans (40 clinical isolates) determined at pH-7.2 | ChEMBL. | 7473549 |
MIC50 (functional) | = 32 ug ml-1 | 50% inhibitory activity against Candida albicans (40 clinical isolates) determined at pH-7.2 | ChEMBL. | 7473549 |
MIC50 (functional) | = 64 ug ml-1 | 50% inhibitory activity against the Candida. species (40 clinical isolates) was determined at pH-7.2 | ChEMBL. | 7473549 |
MIC50 (functional) | = 64 ug ml-1 | 90% inhibitory activity against the Candida. species (40 clinical isolates) was determined at pH-7.2 | ChEMBL. | 7473549 |
MIC50 (functional) | = 64 ug ml-1 | 50% inhibitory activity against Candida albicans (40 clinical isolates) determined at pH-7.2 | ChEMBL. | 7473549 |
MIC50 (functional) | = 64 ug ml-1 | Inhibitory activity against Candida .species (40 clinical isolates), determined at pH-5.8 | ChEMBL. | 7473549 |
MIC50 (functional) | = 64 ug ml-1 | 50% inhibitory activity against Candida albicans (40 clinical isolates) determined at pH-7.2 | ChEMBL. | 7473549 |
MIC90 (functional) | = 64 ug ml-1 | Inhibitory activity against the Candida albicans (40 clinical isolates), determined at pH-7.2 | ChEMBL. | 7473549 |
MIC90 (functional) | = 64 ug ml-1 | Inhibitory activity against the Candida albicans (40 clinical isolates), determined at pH-7.2 | ChEMBL. | 7473549 |
MIC90 (functional) | = 256 ug ml-1 | Inhibitory activity against the Candida albicans (40 clinical isolates), determined at pH-5.8 | ChEMBL. | 7473549 |
MIC90 (functional) | = 256 ug ml-1 | Inhibitory activity against Candida .species (40 clinical isolates), determined at pH-5.8 | ChEMBL. | 7473549 |
MIC90 (functional) | = 256 ug ml-1 | Inhibitory activity against the Candida albicans (40 clinical isolates), determined at pH-5.8 | ChEMBL. | 7473549 |
R (functional) | = 0 % | Resistance against Candida. albicans (40 clinical isolates) at 256 microg/mL (pH=7.2), activity is expressed as R%. | ChEMBL. | 7473549 |
R (functional) | = 0 % | Percent resistance against all Candida. species (40 clinical isolates) at 256 micro g/mL (pH=7.2), activity is expressed as R%. | ChEMBL. | 7473549 |
R (functional) | = 0 % | Percent resistance against Candida albicans (40 clinical isolates) at 256 micro g/mL (pH=5.8), activity is expressed as R%. | ChEMBL. | 7473549 |
R (functional) | = 0 % | Resistance against all Candida. species (40 clinical isolates) at 256 micro g/mL (pH=5.8). Activity is expressed as R%. | ChEMBL. | 7473549 |
R (functional) | = 0 % | Resistance against Candida. albicans (40 clinical isolates) at 256 microg/mL (pH=7.2), activity is expressed as R%. | ChEMBL. | 7473549 |
R (functional) | = 0 % | Percent resistance against Candida albicans (40 clinical isolates) at 256 micro g/mL (pH=5.8), activity is expressed as R%. | ChEMBL. | 7473549 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.